Bcl-2 does not protect Burkitt's lymphoma cells from oxidant-induced cell death

Blood

Volumn 89, Issue 12, 1997, Pages 4480-4492

  Lee, Yang Ja ^a   Shacter, Emily ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BURKITT LYMPHOMA; CELL DEATH; CELL KILLING; CELL NUCLEUS MEMBRANE; CELL TYPE; ENDOPLASMIC RETICULUM; GENE INDUCTION; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOMA CELL; ONCOGENE; PRIORITY JOURNAL; PROTECTION; TUMOR GROWTH;

EID: 0030912615     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.12.4480     Document Type: Article

References (69)

1. Vaux D, Cory S, Adams J: bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440, 1988
2. Tsujimoto Y, Cossman J, Jaffe E, Croce CM: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440, 1985
3. Reed JC, Miyashita T, Cuddy M, Cho D: Regulation of p26-Bcl-2 protein levels in human peripheral blood lymphocytes. Lab Invest 67:443, 1992
4. Veis DJ, Sentman CL, Bach EA, Korsmeyer SJ: Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J Immunol 151:2546, 1993
5. Merino R, Ding L, Veis DJ, Korsmeyer SJ: Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J 13:683, 1994
6. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
7. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ: bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879, 1991
8. Strasser A, Harris AW, Cory S: bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889, 1991
9. Siegel RM, Katsumata M, Miyashita T, Louie DC, Green MI, Reed JC: Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc Natl Acad Sci USA 89:7003, 1992
10. Miyashita T, Reed JC: bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 52:5407, 1992
11. Zhong LT, Sarafian T, Kane DJ, Charles AC, Mah SP, Edwards RH, Bredesen DE: bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 90:4533, 1993
12. Tsujimoto Y, Croce CM: Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83:5214, 1986
13. Cleary M, Smith SD, Sklar J: Cloning and structural analysis of cDNAs for bcl-2 and hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19, 1986
14. Monaghan P, Robertson D, Amos TAS, Dyer MJS, Mason DY, Greaves MF: Ultrastructual localization of Bcl-2 protein. J Histochem Cytochem 40:1819, 1992
15. Jacobson MD, Burnett JF, King MD, Miyashita T, Reed JC, Raff MC: Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361:365, 1993
16. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE: Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 262:1274, 1993
17. Hockenbery DM, Oltvai ZN, Yin X, Milliman CL, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241, 1993
18. Halliwell B, Gutteridge JMC: Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 186:1, 1990
19. Weitzman SA, Gordon LI: Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis. Blood 76:655, 1990
20. Klebanoff S: Phagocytic cells: Products of oxygen metabolism, in Gallin JI, Goldstein IM, Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. New York, NY, Raven, 1988, p 391
21. Cao W, Carney JM, Duchon A, Floyd RA, Chevion M: Oxygen free radical involvement in ischemia and reperfusion injury to brain. Neurosci Lett 88:233, 1988
22. Granger DN: Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 255:H1269, 1988
23. Chance B, Seis H, Boveris A: Hydroperoxide metabolism in mammalian organs. Physiol Rev 59:527, 1979
24. Stadtman ER: Oxidation of proteins by mixed-function oxidation systems: Implication in protein turnover, ageing and neutrophil function. Trends Biochem Sci 11:11, 1986
25. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN: Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4:327, 1993
26. Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H, Tsujimoto Y: Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374:811, 1995
27. Jacobson MD, Raff MC: Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374:814, 1995
28. Kane DJ, Ord T, Anton R, Bredesen DE: Expression of bcl-2 inhibits necrotic neural cell death. J Neurosci Res 40:269, 1995
29. Sarafian TA, Vartvarian L, Kane DJ, Bredesen DE, Verity MA: bcl-2 expression decreases methyl mercury-induced free-radical generation and cell killing in a neural cell line. Toxicol Lett 74:149, 1994
30. Fang W, Rivard JJ, Gancer JA, LeBien TW, Nath KA, Mueller DL, Behrens TW: Bcl-xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. J Immunol 155:66, 1995
31. Albrecht H, Tschopp J, Jongeneel CV: Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-kB by TNF. FEBS Lett 351:45, 1994
32. Magrath I: The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 55:133, 1990
33. Taub R, Moulding C, Batty J, Murphy W, Vasicek T, Lenoir G, Leder P: Activation and somatic mutation of the translocated c-myc gene in Burkitt's lymphoma cells. Cell 36:339, 1984
34. Yano T, van Krieken HJM, Magrath IT, Longo DL, Jaffe ES, Raffeld M: Histogenetic correlations between subcategories of small noncleaved cell lymphomas. Blood 79:1282, 1992
35. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R: p53 mutation in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88:5413, 1991
36. Gala JL, Vermylen C, Cornu G, Ferrant A, Michaux JL, Philippe M, Martiat P: High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis. Ann Hematol 69:17, 1994
37. Finke J, Lange W, Mertelman R, Dolken G: BCL-2 induction is part of the strategy of Epstein-Barr virus. Leuk Lymphoma 12:413, 1994
38. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107, 1991
39. Liu Y, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, MacLennan ICM: Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 21:1905, 1991
40. Finke J, Fritzen R, Ternes P, Trivedi P, Bross KJ, Lange W, Mertelsmann R, Dolken G: Expression of bcl-2 in Burkitt's lymphoma cell lines: Induction by latent Epstein-Barr virus genes. Blood 80:459, 1992
41. Wiman KG, Magnusson KP, Ramqvist T, Klein G: Mutated p53 detected in a majority of Burkitt's lymphoma cell lines by monoclonal antibody PAb240. Oncogene 6:1633, 1991
42. Farrell PJ, Allan GJ, Shanahan F, Vousden KH, Crook T: p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J 10:2879, 1991
43. O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn KW: Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res 53:4776, 1993
44. Fan S, El-Deiry WS, Freeman J, Jondle D, Bhatia K, Fornace AJ Jr, Magrath I, Kohn KW, O'Connor PM: p53 gene mutation are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54:5824, 1994
45. Bhatia K, Goldschmidts W, Gutterrez M, Gaidano G, Dalla-Favera R, Magrath I: Hemi-or homozygosity: A requirement for some but not other p53 mutant proteins to accumulate and exert a pathogenic event. FASEB J 7:951, 1993
46. Pick E, Keisari Y: A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods 38:161, 1980
47. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
48. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets. Proc Natl Acad Sci USA 76:4350, 1979
49. Smith CA, Williams G, Kingston R, Jenkinson EJ, Owen JJT: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337:181, 1989
50. Gold R, Schmeid M, Rothe G, Zischler H, Breitschopf H, Wekerle H, Lassmann H: Detection of DNA fragmentation in apoptosis: Application of in situ nick translation to cell culture system and tissue sections. J Histochem Cytochem 41:1023, 1993
51. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348, 1995
52. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE, Wyllie AH: Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta 1133:275, 1992
53. Milner AE, Johnson GD, Gregory CD: Prevention of programmed cell death in Burkitt lymphoma cell lines by bcl-2 dependent and -independent mechanisms. Int J Cancer 52:636, 1992
54. Oltvai Z, Milliman C, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609, 1993
55. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
56. Wyllie AH, Duvall E, Blow JJ: Cell ageing and cell death, in Davies I, Sigee DC (eds): Cell Ageing and Cell Death. Cambridge University Press, Cambridge, UK, 1984, p 269
57. Newman SL, Henson JE, Henson PM: Phagocytosis of senescent neutrophils by human-derived macrophages and rabbit inflammatory macrophages. J Exp Med 156:430, 1982
58. Lennon SV, Martin SJ, Cotter TG: Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 24:203, 1991
59. Collins RJ, Harmon BV, Gobe GC, Kerr JFR: Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol 61:451, 1992
60. Cohen GM, Sun XM, Snowden RT, Dinsdale D, Skilleter DN: Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 286:331, 1992
61. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M: Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12:3679, 1993
62. Telford WG, King LE, Fraker PJ: Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Methods 172:1, 1994
63. Hu ZB, Yang GS, Li M, Miyamoto N, Minden MD, McGulloch EA: Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukimia: Involvement of free radicals. Leukemia 9:789, 1995
64. Nunez G, Merino R, Grillot D, Gonzalez-Garcia M: Bcl-2 and Bcl-x: Regulatory swiches for lymphoid death and survival. Immunol Today 15:582, 1994
65. Wolfe JT, Ross D, Cohen GM: A role for metals and free radicals in the induction of apoptosis in thymocytes. FEBS Lett 352:58, 1994
66. Slater AF, Nobel CSI, Maellaro E, Bustamante J, Kimland M, Orrenuis S: Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway of thymocyte apoptosis. Biochem J 306:771, 1995
67. Greenlund LJS, Dechwerth TL, Johnson EM Jr: Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death. Neuron 14:303, 1995
68. Verhaegen S, McGowan AJ, Brophy AR, Fernandes RS, Cotter TG: Inhibition of apoptosis by antioxidants in the human HL-60 leukemia cell line. Biochem Pharmacol 50:1021, 1995
69. Malorni W, Rivabene R, Santini MT, Donelli G: N-acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells. FEBS Lett 327:75, 1993